Cohen & Steers, Inc (CNS) Stock Price

65.61 ▼ -0.92 (-1.38%)
Open: 66.46 Vol: 151.04K Day's range: 64.82 - 66.55 Sep 30, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CNS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 65.55▲ 65.27▲ 65.26▲ 66.31▼ 68.95▼
MA10 65.48▲ 65.14▲ 65.62▲ 67.36▼ 71.53▼
MA20 65.31▲ 65.65▲ 65.94▼ 69.35▼ 73.77▼
MA50 65.11▲ 66.04▼ 66.64▼ 72.46▼ 82.55▼
MA100 65.54▲ 66.83▼ 68.52▼ 74.85▼ 79.08▼
MA200 65.92▼ 68.70▼ 70.88▼ 79.51▼ 74.16▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.039▲ 0.034▲ -0.008▼ -0.280▼ -0.563▼
RSI 75.120▲ 51.298▲ 44.812▼ 27.071▼ 31.579▼
STOCH 88.790▲ 53.582     19.389▼ 9.842▼ 15.672▼
WILL %R 0.000▲ -47.989     -56.699     -89.535▼ -94.351▼
CCI 157.125▲ 48.276     -18.691     -104.396▼ -179.399▼
Latest Filters Detected On CNS
▼ BREAK $CNS Price Breaks 60 Days Low Set Alert
▼ BREAK $CNS Price Breaks 30 Days Low Set Alert
▼ BREAK $CNS Price Breaks 20 Days Low Set Alert
▼ BREAK $CNS Price Breaks 10 Days Low Set Alert
Cohen & Steers, Inc News
FDA Guidance Sets Lantern Pharma Inc. (NASDAQ: LTRN) On A Path Toward Realizing Its Clinical Trial Plans For Rare Pediatric Cancer Therapy
Wednesday, October 01, 2025 12:15 AM
On A Path Toward Realizing Its Clinical Trial Plans For Rare Pediatric Cancer Therapy. Texas-based clinical-stage biotechnology company Lantern Pharma Inc. is developing a number of clinical ...
NLS Pharmaceutics stock tumbles after merger approval with Kadimastem
Tuesday, September 30, 2025 08:53 AM
Under the approved terms, Kadimastem shareholders will own 84.4% of the combined company, while NLS shareholders will retain just 15.6% ownership. This exchange ratio reflects the relative value ...
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access
Tuesday, September 30, 2025 05:46 AM
Mr. Kamath brings more than 25 years of market access, pricing, and commercial operations experience to Tonix On August 15, 2025, the U.S. Food and Drug Administration approved Tonmya™ ...
CNS historical stock data
date open high low close volume
30/09/25 66.46 66.55 64.82 65.61 151,040
29/09/25 66.71 67.12 65.71 66.53 183,784
26/09/25 66.40 66.97 66.18 66.41 216,700
25/09/25 66.36 66.645 65.84 66.37 208,811
24/09/25 67.34 67.42 66.2794 66.64 188,657
23/09/25 67.20 68.11 66.98 67.31 438,000
22/09/25 68.37 68.53 67.19 67.27 237,283
19/09/25 69.74 69.74 68.47 68.59 520,851
18/09/25 69.62 70.38 69.41 69.54 167,000
17/09/25 69.38 71.43 69.085 69.35 211,827
Quote Details
52wk Low:64.82
52wk High:110.67
Vol:151.04K
Avg Vol(3m):5.1M
1Y Chng:-33.19%
1M Chng:-12.00%
Add to Watch List
More Information
Index N/A
Market Cap. 3.39B